Pharma Topics

Trending

Wribate
PharmaGlobal

GLP-1 weight-loss drugs lock patients into lifelong dependence instead of fixing the causes of obesity.

04-Nov-2026

GLP-1 drugs such as semaglutide produce substantial weight loss, but many patients regain weight when they stop taking them. Critics say this creates open-ended dependence while food environments and lifestyles stay unchanged. Supporters say obesity is a chronic disease like high blood pressure, and that long-term treatment is as legitimate as any other.

04-Nov-2026
Wribate
PharmaGlobal

Intellectual property regimes severely impede the equitable global distribution of critical, life-saving medical innovations.

23-Jul-2026

Public Health Policy

23-Jul-2026
1 topics remaining
Pharma Topics | Wribate | Wribate